Celanese to Expand Engineered Materials Compounding Capacity at Three Asia Manufacturing Plants
Wed, March 24 2021
Demand growth will outpace current capacity for compounded polymers
To support the significant business growth expected,
Nanjing, China Compounding and LFT Expansion: the intended scope of this project adds approximately 52KT of compounding and long-fiber thermoplastics (LFT) capacity at the company’s Nanjingintegrated chemical complex by the second half of 2023.
Suzhou, ChinaNylon Expansion: the intended scope of this project adds approximately 7KT of nylon compounding capacity at the company’s Suzhoufacility by the second quarter of 2022.
India Compounding Expansion: the intended scope of this project adds approximately 7KT of annual compounding capacity at the company’s Silvassa,
Indiafacility by the first quarter of 2022.
“By continuing to increase our
Financial details of these engineered materials compounding expansions are not being disclosed at this time. Additional project details will be announced as further developments are available.
Forward-Looking Statements: This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company or its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from the forward-looking statements contained in this release. Risk factors include those that are discussed in the Company’s filings with the
+1 972 443 8509
Media Relations – Global
+1 972 443 3750
Media Relations Europe (
+49 69 45009 1206